Healthy-building research reaching a Japanese patent

Research reaching practice

Professor Amir’s first-authored sick-building syndrome review is cited in the technical description of a granted Japanese patent concerning mouse depression and anxiety biomarkers. The review appears in the indoor-environment discussion that precedes the experimental rationale.

The documented contribution

Granted 3 July 2023 · Paragraphs 0026, 0045 and bibliography 0050. The inventors are Keiko Kato and Akiko Fujita. This is a research citation in the patent description; it does not establish Amir’s inventorship, patent ownership, clinical validation or commercial deployment.

• Original source — Granted 3 July 2023 · Paragraphs 0026, 0045 and bibliography 0050
  Original ↗
• Original co-authored research
  Original ↗